Medically reviewed by Eland Siddle, PharmD · Last updated July 2026
When a child takes a medication, their body has to process it: absorb it, break it down, and clear it out. Much of that processing is directed by genes. Two children the same age and weight can respond very differently to the same dose of the same drug, and genetics is often a key reason why.
This field of medicine is called pharmacogenomics: the study of how genes influence drug response. Understanding it helps explain why finding the right medication sometimes takes longer for some children than others, and why that process doesn't have to be entirely trial and error. If you'd like a broader introduction to the field, our article What Is Pharmacogenomics? is a good place to start.
How Genes Shape Drug Metabolism
Most medications are processed by enzymes in the liver. Many of those enzymes are encoded by genes, and those genes have natural variations (called variants or polymorphisms) that make the enzyme work faster, slower, or sometimes not at all. Depending on which variants a child inherits, they may fall into one of a few broad metabolizer categories.
Fast vs. Slow Metabolizers
The terms "fast" and "slow" metabolizer describe how quickly a person's body processes a given drug. Neither is inherently good or bad; it depends entirely on the medication involved.
| Metabolizer Type | What It Means | Potential Effect on Drug Response |
|---|---|---|
| Poor (Slow) Metabolizer | The enzyme works slowly or not at all; drug stays in the body longer | Drug may accumulate, increasing the risk of side effects at standard doses |
| Intermediate Metabolizer | Enzyme activity is reduced but not absent | Response may be somewhere between typical and poor |
| Normal (Extensive) Metabolizer | Enzyme works as expected for most of the population | Standard dosing guidelines generally apply |
| Ultrarapid Metabolizer | Enzyme works faster than typical; drug clears quickly | Drug may clear before it has a chance to work, or a prodrug may convert too rapidly |
It is also worth knowing that some drugs are "prodrugs": they are inactive until the body converts them into their active form. For these, being a slow metabolizer can mean the drug never fully activates, while being an ultrarapid metabolizer can mean too much active compound is produced too quickly.
Why the Same Dose Affects Kids Differently
Standard dosing is based on clinical studies conducted in large populations. Those studies establish a dose that works for most people, but not everyone. A child with a slow-metabolizer profile may experience side effects at a dose that another child tolerates easily. A child who is an ultrarapid metabolizer may see little benefit from a standard dose of a medication that works well for their sibling.
These differences are not a sign that anything is wrong. They reflect normal human genetic variation. What matters is recognizing when a child's genetic profile may be relevant to a prescribing decision, so their care team can take it into account.
Drug Classes Where Pharmacogenomics Is Especially Relevant
Genetic variation in drug metabolism has been studied across many medication categories. Research has found that pharmacogenomic factors are particularly relevant in several areas of pediatric medicine:
- Psychiatric and behavioral health medications. A number of medications used for attention, mood, and anxiety are processed by enzymes for which common genetic variants are well characterized.
- Pain management. Certain pain-relief pathways depend on enzyme activity that varies significantly between individuals. This has been an important area of pediatric pharmacogenomics research.
- Cardiovascular medications. Some drugs used to manage heart rhythm or blood pressure have well-documented pharmacogenomic interactions.
- Antiepileptic drugs. Seizure medications can have narrow therapeutic windows, making metabolizer status particularly relevant to dosing.
- Anticoagulants and antiplatelet agents. Effectiveness and safety of certain blood-thinning medications can be influenced by genetic factors.
This is not an exhaustive list, and it is not medical advice about any specific medication. If you have questions about a drug your child has been prescribed, the right conversation is with their prescriber or a genetic counselor, not a decision to change the medication or dose on your own.
Important: Never adjust, stop, or switch your child's medication based on genetic information alone. Pharmacogenomic data is one input into a clinical decision; it does not replace your child's prescriber. Any medication change should be made in partnership with their healthcare team.
What Parents Can Do with This Information
Pharmacogenomic information is most useful when it reaches your child's care team before a prescribing decision is made, not after a difficult experience with a medication has already occurred. Knowing your child's metabolizer profile ahead of time gives their providers an additional data point when selecting medications and doses.
If your child has had an unexpected reaction to a medication, or has not responded as expected, it may be worth discussing pharmacogenomic testing with their physician. A board-certified genetic counselor can help interpret results in the context of your child's health history and share findings with their care team in a clinically useful way.
For more on the broader topic of medication-related genetic findings, see our article on adverse drug reactions and genetics.
Where Fore Fits In
Fore Genomics offers an at-home pediatric genetic health screen built on whole genome sequencing, the most comprehensive form of genetic testing available. The screen covers 1,000+ genetic conditions and over 100 medication interactions, giving families and their care teams a detailed picture of a child's genetic health from a single cheek swab.
Every screen includes board-certified genetic counseling to help families and their physicians understand and act on the results. The lab is CLIA-certified and CAP-accredited, and results are updated over a child's lifetime as the science evolves, so pharmacogenomic findings discovered years from now can still inform care.
If you'd like to learn more about what whole genome sequencing covers, our article on what whole genome sequencing is explains the technology in plain language.
Learn more about the Fore Genomics screen at www.foregenomics.com.
Personalized Care, Not Prediction
How your child responds to medication isn't trivia. It's information a doctor can act on. Traditional medicine tends to ask one question: is my child sick? Fore is built around a different one: how do we help keep them healthy? That shift matters, because a genetic finding is not a diagnosis.
- A variant is not a verdict. Most children who carry one will never develop the associated condition.
- It points to personalized care, not a fixed fate. A finding identifies who may benefit from closer attention, not who is destined to get sick.
- It gives your pediatrician a head start. Depending on the finding, that can mean earlier eye or hearing exams, periodic heart monitoring, earlier cholesterol screening, avoiding a specific medication, or simply noting the result to watch over time.
- The goal isn't predicting the future. It's making your child's care more personalized from day one.
Fore's at-home whole genome screen covers 1,000+ conditions and 100+ medication responses, includes board-certified genetic counseling, and reanalyzes your child's genome over time as science advances. See what Fore screens for.
FAQs
Can a child's genes really change how a medication works?
Yes. Genes influence the enzymes responsible for processing many medications. Depending on which genetic variants a child has, they may break down a drug faster or slower than expected, which can affect both how well the drug works and how likely they are to experience side effects.
What is a metabolizer type, and how do I find out my child's?
Metabolizer type describes how efficiently a person's body processes a given drug: poor, intermediate, normal (extensive), or ultrarapid. It is determined by variants in specific genes. Pharmacogenomic testing, including the type performed as part of a comprehensive genetic health screen, can identify these variants. A genetic counselor can help interpret what the results mean for your child.
If my child's genes suggest they are a slow metabolizer, should I change their dose?
No, not without involving their prescriber. Pharmacogenomic results are a clinical tool to share with their physician or genetic counselor, not a reason to adjust medication on your own. Dosing decisions must account for many factors, and their care team is best positioned to apply this information safely.
Does pharmacogenomic information apply to all medications?
No. Pharmacogenomics is most relevant for medications processed by specific enzymes for which common genetic variants have been well studied. Many drugs are not significantly affected by the variants typically screened. A genetic counselor can identify which medications in your child's care plan are most relevant to their genetic profile.
At what age can a child get pharmacogenomic screening?
Pharmacogenomic variants are present from birth and do not change over time. Testing can be done at any age, and results remain relevant throughout a person's life. Many families choose to screen early, before a child encounters a situation where the information would be needed, so the data is already available when it matters.